Differential DNA methylation in blood as potential mediator of the association between ambient PM<sub>2.5</sub> and cerebrospinal fluid biomarkers of Alzheimer's disease among a cognitively normal population-based cohort.

Mol Psychiatry · 2026 · PMC13358818 · PMID 42270761

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

nominally significantp < 0.05actually significant

The 295 nominally significant GO terms (raw p < 0.05) and the top 20 KEGG pathways were summarized in the Supplement ( Table S7 , S8 ).

also in 6,427 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Differential DNA methylation in blood as potential mediator of the association between ambient PM&lt;sub&gt;2.5&lt;/sub&gt; and cerebrospinal fluid biomarkers of Alzheimer's disease among a cognitively normal population-based cohort.

The sentences

Differential DNA methylation in blood as potential mediator of the association between ambient PM<sub>2.5</sub> and cerebrospinal fluid biomarkers of Alzheimer's disease among a cognitively normal population-based cohort.